Enveda raises $130M series C to take more AI-discovered compounds into the clinic
Enveda, a company using artificial intelligence to boost nature-based drug discovery, is envisioning clinical success with a $130 million series C fundraising round. | Enveda, a company using AI to...
fiercebiotech.com